Pages that link to "Q40553146"

The following pages link to Vitamin K and the oral anticoagulant drugs (Q40553146):

Displaying 23 items.

• Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome (Q24185813) (← links)
• Topical issues in venous thromboembolism (Q33393312) (← links)
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy (Q34196283) (← links)
• Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q34252907) (← links)
• Plasma disposition of vitamin K1 in relation to anticoagulant poisoning (Q34621595) (← links)
• Stroke Prevention in Atrial Fibrillation: Where are We Now? (Q35811581) (← links)
• Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know (Q37863679) (← links)
• Bismuth compounds in medicinal chemistry. (Q38031636) (← links)
• Oral anticoagulants and status of antidotes for the reversal of bleeding risk. (Q38239244) (← links)
• Clinical Pharmacokinetics of Oral Anticoagulants (Q39787840) (← links)
• The vitamin K-dependent carboxylation reaction (Q40173350) (← links)
• Thrombin specificity (Q40312895) (← links)
• Hemostasis and disorders of coagulation (Q40321069) (← links)
• Pharmacokinetic optimisation of the treatment of deep vein thrombosis (Q40905445) (← links)
• Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations (Q41293004) (← links)
• Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo (Q42062867) (← links)
• Trauma and oral anticoagulants (Q42089542) (← links)
• Anticoagulation therapy in children. (Q43990299) (← links)
• Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin (Q46912948) (← links)
• Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor (Q53941042) (← links)
• Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial) (Q56968101) (← links)
• gamma-Carboxyglutamic acid (Q69926294) (← links)
• Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide (Q70899847) (← links)